The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Open accessAbstract
SUMMARY In obesity, macrophages and other immune cells accumulate in insulin target tissues, promoting a chronic inflammatory state and insulin resistance. Galectin-3 (Gal3), a lectin mainly secreted by macrophages, is elevated in both obese subjects and mice. Administration of Gal3 to mice causes insulin resistance and glucose intolerance, whereas inhibition of Gal3, through either genetic or pharmacologic loss of function, improved insulin sensitivity in obese mice. In vitro treatment with Gal3 directly enhanced macrophage chemotaxis, reduced insulin stimulated glucose uptake in myocytes and 3T3-L1 adipocytes and impaired insulin-mediated suppression of glucose output in primary mouse hepatocytes. Importantly, we found that Gal3 can bind directly to the insulin receptor (IR) and inhibit downstream IR signaling. These observations elucidate a novel role for Gal3 in hepatocytes, adipocytes and myocyte insulin resistance, suggesting that Gal3 can link inflammation to decreased insulin sensitivity. Inhibition of Gal3 could be a new approach to treat insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Self-citationHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
Self-citationInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
Galectins. Structure and function of a large family of animal lectins.
Barondes, S. H., Cooper, D. N., Gitt, M. A., & Leffler, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31891-4 · Cited by 1,496
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Galectins: A family of animal β-galactoside-binding lectins
Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Drickamer, K., Felzi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K.-I., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90498-7 · Cited by 1,223
He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 976
Self-citationGalectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804
Self-citationNonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Birkenfeld, A. L., & Shulman, G. I. (2014) · Hepatology · doi:10.1002/hep.26672 · Cited by 738
Jager, J., Grémeaux, T., Cormont, M., Le Marchand-Brustel, Y., & Tanti, J.-F. (2007) · Endocrinology · doi:10.1210/en.2006-0692 · Cited by 695
Regulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
Self-citationKolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Self-citationLee, Y. S., Kim, J.-W., Osborne, O., Oh, D. Y., Sasik, R., Schenk, S., Chen, A., Chung, H., Murphy, A., Watkins, S. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.012 · Cited by 598
Self-citationHuman Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Sano, H., Hsu, D. K., Yu, L., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., & Liu, F.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2156 · Cited by 521
Ahmad, N., Gabius, H.-J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., & Brewer, C. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312834200 · Cited by 517
THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment
Reaven, G. M. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132155 · Cited by 516
Epidemic Obesity and the Metabolic Syndrome
Haffner, S., & Taegtmeyer, H. (2003) · Circulation · doi:10.1161/01.cir.0000088845.17586.ec · Cited by 427
Galectins: regulators of acute and chronic inflammation
Liu, F., & Rabinovich, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05131.x · Cited by 405
Liu, F., Hsu, D. K., Zuberi, R. I., Kuwabara, I., Chi, E. Y., & Henderson, W. R. (1995) · Europe PMC (PubMed Central) · Cited by 403
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338
Stanley, T. L., Zanni, M. V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., Khor, V. K., Ahima, R. S., & Grinspoon, S. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1170 · Cited by 321
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes
Li, P., Oh, D. Y., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3800 · Cited by 315
Self-citationMechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes
Olefsky, J. M., & G. Kolterman, O. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90422-8 · Cited by 308
Self-citationPillon, N. J., Bilan, P. J., Fink, L. N., & Klip, A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00553.2012 · Cited by 287
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Li, L.-C., Li, J., & Gao, J. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218370 · Cited by 261
Kupffer cell activation is a causal factor for hepatic insulin resistance
Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P. D., & Leclercq, I. A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00391.2009 · Cited by 257
Sato, S., Ouellet, N., Pelletier, I., Simard, M., Rancourt, A., & Bergeron, M. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1813 · Cited by 253
Sato, S., & Hughes, R. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41797-2 · Cited by 246
Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice
Li, P., Lu, M., Nguyen, M. T. A., Bae, E. J., Chapman, J., Feng, D., Hawkins, M., Pessin, J. E., Sears, D. D., Nguyen, A.-K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100263 · Cited by 237
Self-citationNCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids
Li, P., Spann, N. J., Kaikkonen, M. U., Lu, M., Oh, D. Y., Fox, J. N., Bandyopadhyay, G., Talukdar, S., Xu, J., Lagakos, W. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.054 · Cited by 177
Self-citationMechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization
Sears, D. D., Hsiao, G., Hsiao, A., Yu, J. G., Courtney, C. H., Ofrecio, J. M., Chapman, J., & Subramaniam, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903032106 · Cited by 177
Self-citationG Alpha-q/11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes
Imamura, T., Vollenweider, P., Egawa, K., Clodi, M., Ishibashi, K., Nakashima, N., Ugi, S., Adams, J. W., Brown, J. H., & Olefsky, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6765 · Cited by 172
Self-citationPejnovic, N. N., Pantic, J. M., Jovanovic, I. P., Radosavljevic, G. D., Milovanovic, M. Z., Nikolic, I. G., Zdravkovic, N. S., Djukic, A. L., Arsenijevic, N. N., & Lukic, M. L. (2013) · Diabetes · doi:10.2337/db12-0222 · Cited by 172
Joo, H., Goedegebuure, P. S., Sadanaga, N., Nagoshi, M., von Bernstorff, W., & Eberlein, T. J. (2001) · PubMed · Cited by 159
Iacobini, C., Menini, S., Ricci, P. C., Fantauzzi, C. B., Scipioni, A., Salvi, L., Cordone, S., Delucchi, F., Sérino, M., Federici, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.020 · Cited by 152
Feng, B., Jiao, P., Nie, Y., Kim, T., Jun, D., van Rooijen, N., Yang, Z., & Xu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024358 · Cited by 145
Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes
Joo, H., Goedegebuure, P. S., Sadanaga, N., Nagoshi, M., von Bernstorff, W., & Eberlein, T. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.555 · Cited by 130
1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
Salameh, B. A. B., Cumpstey, I., Sundin, A., Leffler, H., & Nilsson, U. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.040 · Cited by 118
Baek, J.-H., Kim, S.-J., Kang, H.-G., Lee, H., Kim, J., Hwang, K., Song, J., & Chun, K. (2014) · Endocrinology · doi:10.1210/en.2014-1374 · Cited by 108
Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
Pang, J., Rhodes, D., Pini, M., Akasheh, R. T., Castellanos, K. J., Cabay, R. J., Cooper, D., Perretti, M., & Fantuzzi, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057915 · Cited by 106
Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation
Lu, M. M., & Shyy, J. Y.-J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00374.2005 · Cited by 92
Self-citationIacobini, C., Menini, S., Ricci, C., Scipioni, A., Sansoni, V., Cordone, S., Taurino, M., Serino, M., Marano, G., Federici, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186791 · Cited by 91
Galectin-3: its role in asthma and potential as an anti-inflammatory target
Gao, P., Simpson, J. L., Zhang, J., & Gibson, P. G. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-136 · Cited by 75
Vollenweider, P., Martin, S. S., Haruta, T., Morris, A. J., Nelson, J. G., Cormont, M., MARCHAND‐BRUSTEL, Y. L., Rose, D. W., & Olefsky, J. M. (1997) · Endocrinology · doi:10.1210/en.138.11.4941 · Cited by 72
Self-citationHuang, J., Imamura, T., Babendure, J. L., Lu, J. C., & Olefsky, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510920200 · Cited by 57
Self-citationGalectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes
Darrow, A. L., & Shohet, R. V. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0230-3 · Cited by 51
Zhong, L., Ding, Y., Bandyopadhyay, G. K., Waaler, J., Börgeson, E., Smith, S. H., Zhang, M., Phillips, S. A., Mahooti, S., Mahata, S. K., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3815-1 · Cited by 44
Self-citationLu, M. M., Li, P., Pferdekamper, J., Fan, W., Saberi, M., Schenk, S., & Olefsky, J. M. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0462 · Cited by 22
Self-citation
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
Self-citationInflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Self-citationAdapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Metadata
- Authors
- Li, P., Liu, S., Lu, M., Bandyopadhyay, G., Oh, D., Imamura, T., Johnson, A. M. F., Sears, D., Shen, Z., Cui, B., Kong, L., Hou, S., Liang, X., Iovino, S., Watkins, S. M., Ying, W., Osborn, O., Wollam, J., Brenner, M., & Olefsky, J. M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 167
- Issue
- 4
- Pages
- 973-984.e12
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2548399475
- Cited by
- 297
- References
- 54
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.